持续气道正压对阻塞性睡眠呼吸暂停合并糖尿病肾病患者白蛋白尿进展的影响:一项随机临床试验
本研究为52周多中心开放标签平行随机临床试验,纳入185例OSA合并DKD患者,随机分为CPAP联合常规治疗组(n=93)或单纯常规治疗组(n=92)。意向性分析显示52周UACR变化组间无显著差异,但符合依从性标准的125例患者方案分析中,CPAP组UACR平均差异为-10.56%(95%CI -19.06至-2.06;P=0.015),提示良好依从性下CPAP可能减少白蛋白尿。
要点
- CPAP治疗未在整体人群中显著降低UACR,但依从性良好者UACR降幅显著。
- CPAP对非嗜睡、更严重OSA、肾功能更差及DKD新诊断者UACR效果更明显。
- CPAP还改善血糖控制、胰岛素抵抗、嗜睡及健康相关生活质量。
核心结论
- 在OSA合并DKD患者中,处方CPAP未导致白蛋白尿显著降低。
- 良好依从CPAP联合常规治疗可能较单纯常规治疗长期减少白蛋白尿。
研究设计与样本
- 52周、多中心、开放标签、平行随机临床试验。
- 纳入185例OSA合并DKD患者,随机分为CPAP联合常规治疗组(n=93)或单纯常规治疗组(n=92)。
主要发现
- 52周UACR较基线变化在CPAP组与常规治疗组间无显著差异。
- 符合预设依从性标准的125例患者方案分析中,CPAP治疗与UACR更大降低相关(平均差异-10.56%[95%CI -19.06至-2.06];P=0.015)。
- CPAP对UACR的效果在非嗜睡、更严重OSA、肾功能更差及DKD诊断更近的患者中更高。
- CPAP治疗还改善血糖控制、胰岛素抵抗、嗜睡及健康相关生活质量。
关键数值与推荐
- 主要结局为52周UACR较基线变化。
- 依从性方案分析纳入125例符合预设依从性标准的参与者。
临床怎么用
- 对OSA合并DKD患者,应关注CPAP依从性以可能获得白蛋白尿减少的长期获益。
- 非嗜睡但OSA更严重、肾功能更差或DKD新诊断者可能从CPAP中更多获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Obstructive sleep apnea (OSA) is associated with impaired glycemic control and a higher risk of vascular complications, such as diabetic kidney disease (DKD). However, the effect of apnea-hypopnea suppression on DKD progression is unclear. Objectives: To assess the effect of continuous positive airway pressure (CPAP) on the urinary albumin-to-creatinine ratio (UACR) in patients with DKD and OSA. Methods: In a 52-week, multicentric, open-label, parallel, and randomized clinical trial, 185 patients with OSA and DKD were randomized to CPAP and usual care (n = 93) or usual care alone (n = 92). Measurements and Main Results: UACR, estimated glomerular filtration rate, serum concentrations of creatinine and glycated hemoglobin, insulin resistance, lipid concentrations, sleepiness, and quality of life. A 52-week change in UACR from baseline did not differ significantly between the CPAP group and the usual-care group. However, in per-protocol analyses that included 125 participants who met prespecified criteria for adherence, CPAP treatment was associated with a great reduction in UACR (mean difference, -10.56% [95% confidence interval, -19.06 to -2.06]; P = 0.015). CPAP effect on UACR was higher in nonsleepy patients with more severe OSA, worse renal function, and a more recent diagnosis of DKD. CPAP treatment also improved glycemic control and insulin resistance, as well as sleepiness and health-related quality of life. Conclusions: In patients with OSA and DKD, the prescription of CPAP did not result in a statistically significant reduction in albuminuria. However, good adherence to CPAP treatment in addition to usual care may result in long-term albuminuria reduction compared with usual care alone. Clinical trial registered with www.clinicaltrials.gov (NCT02816762).
引用
- Zamarrón E, Jaureguizar A, García-Sánchez A, et al. Continuous Positive Airway Pressure Effect on Albuminuria Progression in Patients with Obstructive Sleep Apnea and Diabetic Kidney Disease: A Randomized Clinical Trial. Am J Respir Crit Care Med. 2023. PMID: 36342964. doi:10.1164/rccm.202206-1091OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。